Interferon-β and Anti-PD1/PD-L1 Checkpoint Blocakde Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells

被引：0
|
作者：
Kontny, U. [1 ]
Makowska, A. [1 ]
Braunschweig, T. [2 ]
Shen, L. [1 ]
Denecke, B. [3 ]
机构：
[1] RWTH Univ, Med Ctr, Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany
[2] RWTH Univ, Med Ctr, Pathol, Aachen, Germany
[3] RWTH Univ, Med Ctr, Interdisciplinary Ctr Clin Res, Aachen, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-664
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [1] Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells
    Makowska, Anna
    Braunschweig, Till
    Denecke, Bernd
    Shen, Lian
    Baloche, Valentin
    Busson, Pierre
    Kontny, Udo
    TRANSLATIONAL ONCOLOGY, 2019, 12 (09): : 1237 - 1256
  • [2] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Ikeda, Sadakatsu
    Goodman, Aaron M.
    Cohen, Philip R.
    Jensen, Taylor J.
    Ellison, Christopher K.
    Frampton, Garrett
    Miller, Vincent
    Patel, Sandip P.
    Kurzrock, Razelle
    NPJ GENOMIC MEDICINE, 2016, 1
  • [3] Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
    Sadakatsu Ikeda
    Aaron M Goodman
    Philip R Cohen
    Taylor J Jensen
    Christopher K Ellison
    Garrett Frampton
    Vincent Miller
    Sandip P Patel
    Razelle Kurzrock
    npj Genomic Medicine, 1
  • [4] Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
    Makowska, Anna
    Meier, Selina
    Shen, Lian
    Busson, Pierre
    Baloche, Valentin
    Kontny, Udo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (02) : 323 - 336
  • [5] Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
    Anna Makowska
    Selina Meier
    Lian Shen
    Pierre Busson
    Valentin Baloche
    Udo Kontny
    Cancer Immunology, Immunotherapy, 2021, 70 : 323 - 336
  • [6] Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing
    Sun, Lin-Lin
    Yang, Ri-Yao
    Li, Chia-Wei
    Chen, Mei-Kuang
    Shao, Bin
    Hsu, Jung-Mao
    Chan, Li-Chuan
    Yang, Yi
    Hsu, Jennifer L.
    Lai, Yun-Ju
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (07): : 1307 - +
  • [7] Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
    Del Rio, Maria-Luisa
    Perez-Simon, Jose-Antonio
    Rodriguez-Barbosa, Jose-Ignacio
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
    Hsu, Joy
    Hodgins, Jonathan J.
    Marathe, Malvika
    Nicolai, Chris J.
    Bourgeois-Daigneault, Marie-Claude
    Trevino, Troy N.
    Azimi, Camillia S.
    Scheer, Amit K.
    Randolph, Haley E.
    Thompson, Thornton W.
    Zhang, Lily
    Iannello, Alexandre
    Mathur, Nikhita
    Jardine, Karen E.
    Kirn, Georgia A.
    Bell, John C.
    McBurney, Michael W.
    Raulet, David H.
    Ardolino, Michele
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10): : 4654 - 4668
  • [9] Pretreatment eosinophil counts (PEC) in metastatic urothelial carcinoma (mUC) treated with anti-PD1/PD-L1 checkpoint inhibitors (CPI).
    Mota, Jose Mauricio
    Teo, Min Yuen
    Whiting, Karissa
    Ostrovnaya, Irina
    Li, Han
    Lee, Chung-Han
    Funt, Samuel Aaron
    Callahan, Margaret K.
    Iyer, Gopa
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Targeting the PD-1/PD-L1 interaction in nasopharyngeal carcinoma
    Johnson, David
    Ma, Brigette B. Y.
    ORAL ONCOLOGY, 2021, 113
12345